During the past decade, HFR Fribourg - Hôpital Cantonal conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 6 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 3 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HFR Fribourg - Hôpital Cantonal" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 18 trials, followed by "ETOP IBCSG Partners Foundation" with 3 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored, "University Hospital, Geneva" with 3 trials sponsored and "Biosensors Europe SA" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HFR Fribourg - Hôpital Cantonal" #1 collaborator was "University Hospital Inselspital, Berne" with 3 trials as a collaborator, "University Hospital, Geneva" with 3 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator and "Swiss National Science Foundation" with 2 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "HFR Fribourg - Hôpital Cantonal" are "Coronary Artery Disease" (5 trials), "Rheumatoid Arthritis" (3 trials), "Acute Coronary Syndrome" (2 trials), "Acute Myeloid Leukemia" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "HFR Fribourg - Hôpital Cantonal" in a lesser frequency.

Most popular intervention types in "HFR Fribourg - Hôpital Cantonal" are "Drug" (30 trials), "Other" (14 trials), "Device" (10 trials), "Procedure" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (2 trials), "Dexamethasone" (2 trials), "Midostaurin" (2 trials) and "No intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "HFR Fribourg - Hôpital Cantonal" are 59 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "HFR Fribourg - Hôpital Cantonal". 2 are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in HFR Fribourg - Hôpital Cantonal, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in HFR Fribourg - Hôpital Cantonal, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 15 trials that are defined as “Not Applicable".

HFR Fribourg - Hôpital Cantonal has several departments that took part in Clinical trials: "Freiburger Spital; Onkologie" - 2 trials